Ian Gourley
Technik-/Wissenschafts-/F&E-Leiter bei IMMUNOVANT, INC.
Profil
Ian Gourley currently works at The Royal College of Physicians, as Member and Immunovant, Inc., as Vice President-Clinical Development.
Dr. Gourley also formerly worked at Eli Lilly & Co., as Head-Clinical Research Pathologist and Janssen Pharmaceuticals, Inc., as Head-Translational Medical Science.
Dr. Gourley received his graduate degree from Queen's University of Belfast.
Aktive Positionen von Ian Gourley
Unternehmen | Position | Beginn |
---|---|---|
IMMUNOVANT, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
The Royal College of Physicians | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Ian Gourley
Unternehmen | Position | Ende |
---|---|---|
ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Corporate Officer/Principal | - |
Ausbildung von Ian Gourley
Queen's University of Belfast | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
IMMUNOVANT, INC. | Health Technology |
ELI LILLY AND COMPANY | Health Technology |
Private Unternehmen | 1 |
---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |